In a move to safeguard its dominant position in cancer treatments, Merck agreed to license a drug from a Chinese company ...

In a move to safeguard the company’s dominant position in cancer, Merck said Thursday it will license a new cancer drug from ...

Merck & Co Inc. (MRK) and LaNova Medicines Ltd., a privately held clinical-stage biotechnology company Thursday said Merck has ...

Nava Limited, a leading diversified conglomerate with business interests in metals, energy, mining, commercial agriculture, and healthcare is pleased to announce its financial results for the quarter ...

Driven by growth across the board, including in its semiconductor business, German science and technology company Merck ...

Merck KGaA on Thursday reported a gain of 11.9% in adjusted quarterly earnings, helped by temporarily lower spending on drug ...

Thus describing a pope who goes out to meet people, especially the most needy, so they may find the love of God and his presence in this world, the official website of the trip explains. The logo ...

The Los Angeles Rams' Week 8 victory over the Minnesota Vikings ended in controversy, as Vikings quarterback Sam Darnold was sacked in the end zone for a safety while attempting to engineer a game ...

Merck & Co., Inc.'s Q3 earnings report is anticipated on 31st October — next Thursday. Despite strong Q2 performance, Merck's stock fell due to a guidance downgrade related to issues with key ...

Despite Merck & Co. homing in on approval for its infant respiratory syncytial virus (RSV) antibody clesrovimab, Sanofi—which last year won its own nod for its AstraZeneca-partnered RSV ...

The domain JioHotstar now opens to a basic webpage displaying a “JioHotstar” banner, but without any official logos or branding. The page carries a message from the current domain owner ...